SUBSTANTIAL RISE IN SPARTEINE METABOLIC RATIO DURING HALOPERIDOL TREATMENT

被引:54
作者
GRAM, LF
DEBRUYNE, D
CAILLARD, V
BOULENGER, JP
LACOTTE, J
MOULIN, M
ZARIFIAN, E
机构
[1] UNIV CAEN,HOSP CTR,CTR PSYCHIAT ESQUIROL,F-14032 CAEN,FRANCE
[2] UNIV CAEN,HOSP CTR,PHARMACOL LAB,F-14032 CAEN,FRANCE
关键词
D O I
10.1111/j.1365-2125.1989.tb05362.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:272 / 275
页数:4
相关论文
共 22 条
[1]   NORTRIPTYLINE AND ANTIPYRINE CLEARANCE IN RELATION TO DEBRISOQUINE HYDROXYLATION IN MAN [J].
BERTILSSON, L ;
EICHELBAUM, M ;
MELLSTROM, B ;
SAWE, J ;
SCHULZ, HU ;
SJOQVIST, F .
LIFE SCIENCES, 1980, 27 (18) :1673-1677
[2]  
BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
[3]   SPARTEINE OXIDATION IS PRACTICALLY ABOLISHED IN QUINIDINE-TREATED PATIENTS [J].
BRINN, R ;
BROSEN, K ;
GRAM, LF ;
HAGHFELT, T ;
OTTON, SV .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) :194-197
[4]   IMIPRAMINE DEMETHYLATION AND HYDROXYLATION - IMPACT OF THE SPARTEINE OXIDATION PHENOTYPE [J].
BROSEN, K ;
OTTON, SV ;
GRAM, LF .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (05) :543-549
[5]   EXTENSIVE METABOLIZERS OF DEBRISOQUINE BECOME POOR METABOLIZERS DURING QUINIDINE TREATMENT [J].
BROSEN, K ;
GRAM, LF ;
HAGHFELT, T ;
BERTILSSON, L .
PHARMACOLOGY & TOXICOLOGY, 1987, 60 (04) :312-314
[6]   STEADY-STATE LEVELS OF IMIPRAMINE AND ITS METABOLITES - SIGNIFICANCE OF DOSE-DEPENDENT KINETICS [J].
BROSEN, K ;
GRAM, LF ;
KLYSNER, R ;
BECH, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (01) :43-49
[7]  
DAHLPUUSTINEN ML, 1988, 5TH INT M CLIN PHARM
[8]   GAS-CHROMATOGRAPHIC METHOD FOR DETERMINING HALOPERIDOL - SENSITIVE PROCEDURE FOR STUDYING SERUM CONCENTRATION AND PHARMACOKINETICS OF HALOPERIDOL IN PATIENTS [J].
FORSMAN, A ;
MARTENSSON, E ;
NYBERG, G ;
OHMAN, R .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 286 (02) :113-124
[9]  
GRAM LF, 1975, PSYCHOPHARMACOL COMM, V1, P165
[10]  
GRAM LF, 1988, IN PRESS CLIN PHARM